Basic info
Industry
biotechnology research
Sectors
drug development
Biotechnology
oncology
Therapeutics
antibody drug conjugates
bioconjugation
Medical
Health Care
cancer research
Date founded
2001
Funding rounds raised
Total raised
$65M
from 11 investors over 11 rounds
M
Mersana Therapeutics raised $65M on April 7, 2020
Investors: Avoro Capital Advisors (formerly venBio Select Advisor) and Consonance Capital
M
Mersana Therapeutics raised $33M on June 16, 2016
Investors: Wellington Management
M
Mersana Therapeutics raised $35M on March 2, 2015
Investors: F-Prime Capital Partners
M
Mersana Therapeutics raised $15M on April 8, 2014
Investors: F-Prime Capital Partners
M
Mersana Therapeutics raised $27M on July 31, 2012
Investors: F-Prime Capital Partners and ProQuest Investments
M
Mersana Therapeutics raised $21M on November 8, 2005
Investors: Rho Ventures, PureTech Health, ProQuest Investments and F-Prime Capital Partners